n
Former designation of Nelarabine; a chemotherapy prodrug used in treatment of T-cell acute lymphoblastic leukemia.
n
An experimental drug candidate for the treatment of cancer.
n
An anticancer medication used to treat NSCLC.
n
(pharmacology) A drug against non-small cell lung carcinoma.
n
(medicine) A drug used to treat some forms of cancer
n
A drug used to treat breast cancer
n
(pharmacology) A diuretic C₆H₈ClN₇O that promotes sodium excretion and potassium retention; any elated compound
n
(pharmacology) An anthracycline used in the treatment of lung cancer.
n
The tyrosine kinase inhibitor 1-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxyquinolin-7-yl]oxymethyl]cyclopropan-1-amine
n
Any of a group of peptides and other compounds used in a controversial unproven therapy against cancer.
n
A novel small-molecular agent designed to make ribosomes become less sensitive to, or possibly ignore, premature stop codons.
n
A drug being researched for the treatment of various cancers.
n
A drug for the treatment of certain forms of gastrointestinal stromal tumor.
n
A cytidine analogue used in the treatment of myelodysplastic syndrome.
n
(pharmacology) An antineoplastic drug.
n
An exogenous matrix metalloproteinase inhibitor.
n
A kinase inhibitor used to treat chronic graft-versus-host disease.
n
(pharmacology) A drug with the molecular formula C₁₇H₁₅BrF₂N₄O₃ that inhibits mitogen-activated protein kinase kinase (MEK), and is approved for use in combination with encorafenib to treat certain melanomas.
n
A tyrosine kinase inhibitor undergoing research for use in the treatment of cancer.
n
The anticancer drug 5-chloro-2-N-{4-[4-(dimethylamino)piperidin-1-yl]-2-methoxyphenyl}-4-N-[2-(dimethylphosphoryl)phenyl]pyrimidine-2,4-diamine
n
An experimental drug, so far shown to reduce tumour growth, metastasis, and angiogenesis.
n
An experimental drug for the treatment of cancer.
n
A drug used to treat breast cancer
n
(medicine) A particular polymeric antiangiogenic drug
n
A potent inhibitor of VEGF receptor tyrosine kinases, under development as a possible anticancer drug.
n
A particular drug for the treatment of lung cancer.
n
A cholagogue or choleretic drug.
n
A particular phosphoinositide 3-kinase inhibitor.
n
An investigational drug, a tyrosine kinase inhibitor for the treatment of certain cancers.
n
(pharmacology) An immunosuppressive, antineoplastic drug used in the treatment of Hodgkin's disease and certain other forms of cancer.
n
A particular drug used as a tyrosine kinase inhibitor.
n
Alternative form of dasatinib [A particular drug used as a tyrosine kinase inhibitor.]
n
A hormonal therapy used in the treatment of prostate cancer.
n
A particular drug used in chemotherapy.
n
An antineoplastic agent, an engineered protein combining interleukin-2 and Diphtheria toxin.
n
(medicine) A preparation containing dimethicone
n
An experimental drug that inhibits cyclin-dependent kinases.
n
(pharmacology) A serotonin 5-HT₃ receptor antagonist used to treat nausea and vomiting following chemotherapy.
n
A tyrosine kinase inhibitor drug.
n
A topoisomerase I inhibitor.
n
(pharmacology) A substance which, when bound to various radionuclides, is used in the treatment and diagnosis of certain cancers.
n
A drug that triggers apoptosis in cancer cells.
n
(medicine) A particular anticancer drug
n
(medicine) A particular anticancer drug
n
(medicine) An intensive chemotherapy regimen for treating aggressive non-Hodgkin lymphoma, consisting of etoposide, prednisolone, Oncovin (vincristine), cyclophosphamide, and hydroxydaunorubicin.
n
(organic chemistry, medicine) An inhibitor of some tyrosine kinases that is used to treat some cancers
n
A drug used to treat certain cancers.
n
Alternative form of erlotinib [A drug used to treat certain cancers.]
n
A particular drug used in chemotherapy.
n
A phosphodiesterase 4 inhibitor, used in the therapeutic treatment of asthma and chronic obstructive pulmonary disease.
n
(pharmacology) A corticosteroid.
n
(pharmacology) A particular drug that is an inhibitor of the enzyme spleen tyrosine kinase (Syk).
n
A kinase inhibitor used to treat cholangiocarcinoma.
n
A histone deacetylase inhibitor with potential anti-inflammatory, antiangiogenic and antineoplastic activity.
n
(medicine) A class of drug used to combat nephrotoxicity
n
(pharmacology) A guanoside of decitabine that has antineoplastic activity.
n
A trademarked name for the anti-cancer drug trastuzumab.
n
(pharmacology) A drug used to treat certain types of cancer.
n
An anticancer medication used to treat cholangiocarcinoma.
n
A kinase inhibitor proposed as a preventer of breast cancer
n
A particular oral drug used to treat cancer.
n
A particular oral drug used in the treatment of cancer.
n
A drug used to treat certain thyroid cancers.
n
A particular drug used in the treatment of cancer.
n
Alternative form of lenvatinib [A drug used to treat certain thyroid cancers.]
n
(medicine) A tyrosine kinase inhibitor that has some anticancer properties
n
A selective inhibitor of the p38 mitogen-activated protein kinases.
n
(pharmacology) A particular malononitrilamide derived from teriflunomide.
n
(medicine) A novel matrix metalloprotease inhibitor once proposed for cancer treatment
n
An amino sugar derived from sorbitol.
n
(pharmacology) Any of several pharmaceuticals that contain metals such as silver or platinum; especially such anticancer drugs
n
(pharmacology) A drug, having a phospholipid moiety, used to treat osteosarcoma.
n
A medication used to treat hemolytic anemia.
n
(pharmacology) An antineoplastic alkylating drug.
n
(pharmacology) A particular drug used in chemotherapy.
n
(pharmacology) An immunosuppressive drug.
n
An experimental anticancer drug.
n
(medicine) Abbreviation of methotrexate. [(pharmacology) An antimetabolite and antifolate drug used in treatment of cancer and autoimmune diseases.]
n
(medicine) A drug that induces apoptosis in cancer cells
n
(medicine) A particular anticancer drug
n
(pharmacology) A particular drug used to treat cancer.
n
(pharmacology) A drug used to treat cancer.
n
A particular drug used as part of the treatment regimen for some types of non-small-cell lung cancer and for idiopathic pulmonary fibrosis.
n
A drug being developed as a cancer treatment.
n
An experimental drug candidate for the treatment of various cancers.
n
A protein translation inhibitor drug for the management of treatment-resistant chronic myeloid leukemia and under investigation for some other hematologic cancers.
n
Any drug or substance that breaks up cancer cells.
n
A peptide that is associated with a particular cancer
n
An anticancer medication used to treat myelofibrosis.
n
An antineoplastic agent used to treat acute lymphoblastic leukaemia.
n
An investigational anticancer drug.
n
(pharmacology) A recombinant porcine-like uricase used as a drug to treat severe gout.
n
A particular kinase inhibitor.
n
A particular drug used in chemotherapy.
n
A synthetic antimicrobial peptide developed for the treatment of infection in diabetics.
n
An investigational PI3K inhibitor.
n
A particular inhibitor of Mitogen-activated protein kinase kinase
n
An experimental anticancer drug, a synthetic analog of phenylahistin.
n
An oral drug for the treatment of certain leukemias.
n
A drug used to treat some cancers
n
A tyrosine kinase inhibitor for the treatment of metastatic RET fusion-positive non-small-cell lung cancer.
n
(medicine) The kinase inhibitor 1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[6-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl]urea
n
Alternative form of rapalog [(medicine) Any of several synthetic drugs that are analogues of rapamycin]
n
(pharmacology) A recombinant version of a urate oxidase enzyme that occurs in many mammals but not in humans, used in treating certain tumour-related conditions.
n
The kinase inhibitor N-[3,4-difluoro-2-(2-fluoro-4-iodoanilino)-6-methoxyphenyl]-1-[(2S)-2,3-dihydroxypropyl]cyclopropane-1-sulfonamide
n
(medicine) A particular oral multi-kinase inhibitor
n
A chemical analogue of imiquimod, potentially useful in treating skin cancer.
n
A kinase inhibitor used to treat certain cancers
n
A drug for the treatment of advanced gastrointestinal stromal tumor.
n
A drug being developed as a cancer treatment.
n
A drug that acts as a dual kinase inhibitor, originally developed for the treatment of cancer.
n
(pharmacology) A particular drug used in chemotherapy.
n
A drug used to treat some cancers
n
A drug being researched for the treatment of certain lung cancers and other disorders.
n
(pharmacology) A particular SIRT1 inhibitor drug.
n
A particular anticancer drug.
n
(medicine) A tyrosine kinase inhibitor that is used as an anticancer drug
n
An inhibitor of human neutrophil elastase, used in the treatment of acute respiratory failure.
n
(pharmacology) A small molecule drug used to treat cancer of the kidney and liver.
n
A protein kinase C inhibitor.
n
An oral small-molecule receptor tyrosine kinase (RTK) inhibitor used in the treatment of renal cell carcinoma and imatinib-resistant gastrointestinal stromal tumour.
n
(medicine) A PARP inhibitor used to treat breast cancer
n
(pharmacology) An orally-active synthetic retinoid, developed to overcome all-trans retinoic acid (ATRA) resistance, with potential antineoplastic activity.
n
A particular tubulin-binding drug, a synthetic derivative of dolastatin.
n
A particular antiangiogenic drug.
n
A particular drug used to treat cancer.
n
A tyrosine kinase inhibitor used to treat certain forms of metastatic non-small cell lung cancer.
n
The active metabolite of leflunomide.
n
A farnesyltransferase inhibitor with possible anticancer applications.
n
A staurosporine derivative that binds to the dephosphorylated MET kinase in vitro, and also displays unrelated cytotoxic activity.
n
The international nonproprietary name of a COVID-19 vaccine developed by BioNTech in cooperation with Pfizer.
n
A particular anticancer drug.
n
A medication used to reduce the frequency of chemotherapy-induced bone marrow suppression.
n
An antigen used in the diagnosis of tuberculosis.
n
(organic chemistry, medicine) A kinase inhibitor used to treat some breast cancers
n
An anticancer drug used to treat certain tumors of the thyroid gland.
n
A potential anticancer drug acting as a PARP inhibitor.
n
(pharmacology) An antiviral drug C₁₀H₁₃N₅O₄·H₂O, a form of arabinofuranosyladenine, which is active against herpes simplex and varicella zoster viruses.
n
A drug for the treatment of basal-cell carcinoma.
n
An experimental anticancer drug. It is a dihydropteridinone derivative.
n
A particular antineoplastic drug
n
An endothelin receptor antagonist under investigation as an anticancer drug.
n
An aldose reductase inhibitor.
Note: Concept clusters like the one above are an experimental OneLook
feature. We've grouped words and phrases into thousands of clusters
based on a statistical analysis of how they are used in writing. Some
of the words and concepts may be vulgar or offensive. The names of the
clusters were written automatically and may not precisely describe
every word within the cluster; furthermore, the clusters may be
missing some entries that you'd normally associate with their
names. Click on a word to look it up on OneLook.
Our daily word games Threepeat and Compound Your Joy are going strong. Bookmark and enjoy!
Today's secret word is 7 letters and means "Property or assets, excluding real estate." Can you find it?